Arch Therapeutics Debt 2024

Arch Therapeutics Aktienanalyse

What does Arch Therapeutics do?

Arch Therapeutics Inc. is a Massachusetts-based company specializing in the development of medical devices. The company was founded in 2006 and has expanded its activities to manufacturing innovative medical products that can be used in various surgical procedures. The business model of Arch Therapeutics is based on the development of medical devices that aim to enable faster recovery for patients. The company utilizes a patented technology platform called "AC5" for the manufacturing and marketing of devices for various medical applications. The company has various divisions specializing in different medical applications. One main focus is the development of devices for hemostasis (blood clotting) in surgery, which is currently in the testing phase. Arch Therapeutics aims to provide a better alternative to existing solutions such as surgical clips or sutures, which are often associated with undesirable side effects. Another focus of Arch Therapeutics is the manufacturing of devices for dermatology. The company has developed a technology that enables a new and unique process for the rapid healing of wounds. This process is especially relevant for the treatment of difficult-to-heal wounds and chronic wounds. The company also has a division for ophthalmic surgery, which has developed a patented device technology for the treatment of glaucoma-related issues. This technology is intended to be a better alternative to conventional treatment methods such as eye drops. Arch Therapeutics' portfolio includes a wide range of medical devices and solutions for various medical applications. These products are designed to enable better patient recovery and have been developed by a group of experts, ensuring high quality and effectiveness. The offered products also include dermatology products, adhesion barriers, surgical J-clips, as well as wound closure and hemostasis devices. Overall, Arch Therapeutics has a strong potential for growth and expansion in the medical device industry. The company has already obtained patents for its AC5 platform and developed a wide range of products for various medical applications. With a dedicated team of employees, the company has laid a strong foundation for its future and is expected to remain a leading provider of medical devices in the coming years. Arch Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Arch Therapeutics's Debt Structure

Arch Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Arch Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Arch Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Arch Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Arch Therapeutics Stock

What is the debt of Arch Therapeutics this year?

Arch Therapeutics has a debt level of 5.41 USD this year.

What was the debt of Arch Therapeutics compared to the previous year?

The debt of Arch Therapeutics has increased by 107.09% compared to the previous year increased.

What are the consequences of high debt for investors in Arch Therapeutics?

High debt can pose a risk for investors of Arch Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Arch Therapeutics?

Low debt means that Arch Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Arch Therapeutics affect the company?

An increase in debt of Arch Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Arch Therapeutics affect the company?

A reduction in debt of Arch Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Arch Therapeutics?

Some factors that can influence the debt of Arch Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Arch Therapeutics so important for investors?

The debts of Arch Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Arch Therapeutics take to change the debt?

To change the debt, Arch Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Arch Therapeutics pay?

Over the past 12 months, Arch Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arch Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Arch Therapeutics?

The current dividend yield of Arch Therapeutics is .

When does Arch Therapeutics pay dividends?

Arch Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arch Therapeutics?

Arch Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Arch Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arch Therapeutics located?

Arch Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arch Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arch Therapeutics from 6/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Arch Therapeutics pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Arch Therapeutics in the year 2023?

In the year 2023, Arch Therapeutics distributed 0 USD as dividends.

In which currency does Arch Therapeutics pay out the dividend?

The dividends of Arch Therapeutics are distributed in USD.